A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5 -dioxo-oxazolidine intermediate compounds

Details for Australian Patent Application No. 2002328954 (hide)

Owner ADIR

Inventors Cid, Pau

Agent Griffith Hack

Pub. Number AU-B-2002328954

PCT Number PCT/EP02/08223

PCT Pub. Number WO2003/010142

Priority 01500197.7 24.07.01 EP

Filing date 23 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 4 October 2007

International Classifications

C07D 263/44 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07C 227/18 (2006.01) Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/062 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07C 229/16 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 01500197.7 24.07.01 EP

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002328954

4 October 2007 Application Accepted

  Published as AU-B-2002328954

31 January 2008 Standard Patent Sealed

3 April 2008 Licence Registered

  ADIR ( Servier Laboratories (Australia) Pty Ltd )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002328955-Water-in-oil polymer dispersion as additive in compositions containing active ingredients

2002328953-MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON MDR1